Latest Rosuvastatin Stories
WALTHAM, Mass., April 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a dyslipidemia drug that is dosed once a week would earn 40 percent patient share in the U.S., according to surveyed U.S.
WILMINGTON, Del. and ABBOTT PARK, Ill., March 30 /PRNewswire-FirstCall/ -- AstraZeneca and Abbott (NYSE: ABT) announced today that the U.S.
Highest approved dose of cholesterol-lowering medication could cause harm to muscles SILVER SPRING, Md., March 19 /PRNewswire-USNewswire/ -- The U.S.
OSAKA, Japan, ATLANTA and ANN ARBOR, Mich., March 2 /PRNewswire/ -- Shionogi & Co., Ltd.
WILMINGTON, Del., Feb.
WILMINGTON, Del., Dec. 15 /PRNewswire-FirstCall/ -- The U.S.
WILMINGTON, Del., Dec. 11 /PRNewswire-FirstCall/ -- Today, the U.S.
ORLANDO, Fla., Nov.
NANJING, China, Nov.
WILMINGTON, Del., Oct. 16 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the U.S.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.